Malignant Germ Cell Tumor — Trials

Malignant Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06275854	YASU Research Registry: For Young Adults With Cancer	terminated	—	192	Young Adult Survivors UnitedOTHER	1	Oct 14, 2025	clinicaltrials
NCT01593241	Therapy De-escalation in Seminoma Stage IIA/B	terminated	Phase 2	120	Swiss Cancer InstituteOTHER	2	Feb 13, 2025	clinicaltrials
NCT01055067